Drawing for DE-ESCALATION THERAPY

USPTO serial 76315264

DE-ESCALATION THERAPY

Reviewed by CopyMark Law Group

Reg. 2743991Status 710
Filing date
Status date
Registration date
Jul 29, 2003
Examiner
DEJESUS, YSA
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DE-ESCALATION THERAPY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert Peverada

Robert Peverada Merck & Co., Inc.One Merck Drive, P.O. Box 100WHITEHOUSE STATION, NJ 08889-0100UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
041Educational services, namely, conducting symposiums on anti-infectivesSECTION 8 - CANCELLEDMar 26, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 7, 2014CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jun 13, 2012ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 30, 2012ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 3, 2010CORVREVIEW OF CORRESPONDENCE COMPLETE—
Jan 11, 2010MAILPAPER RECEIVED—
Dec 9, 2009ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 2, 2009ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 1, 20098.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jun 24, 2009PLGLASSIGNED TO PARALEGAL—
Jun 22, 2009ES8RTEAS SECTION 8 RECEIVED—
Jul 29, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 30, 2003CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 29, 2003CFITCASE FILE IN TICRS—
May 22, 2003SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 15, 2003EX1GSOU EXTENSION 1 GRANTED—
Apr 4, 2003MAILPAPER RECEIVED—
Apr 3, 2003IUAFUSE AMENDMENT FILED—
Jan 9, 2003EXT1SOU EXTENSION 1 FILED—
Jan 9, 2003MAILPAPER RECEIVED—
Aug 13, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 21, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 1, 2002NPUBNOTICE OF PUBLICATION—
Dec 12, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 6, 2001CNEAEXAMINER'S AMENDMENT MAILED—
Dec 3, 2001DOCKASSIGNED TO EXAMINER—
Dec 2, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance